InsiderTrades

Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-29 · accession 0001104659-24-096367 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-09-03 2024-08-29 OCUL Notman Donald See Remarks A - Grant $0.00 +11.0K 209.0K +6% $0
D 2024-09-03 2024-08-29 OCUL Notman Donald See Remarks A - Grant $0.00 +33.6K 33.6K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-29 A A 11,034 $0.00 208,988 D — — (F1) On August 29, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter. (F2) Includes 2,598 shares of common stock acquired under the 2014 Ocular Therapeutix, Inc. Employee Stock Purchase Plan on June 30, 2024.
2 Derivative Stock Option (Right to Buy) 2024-08-29 A A 33,602 $0.00 33,602 D $8.56 · — to 2034-08-28 33,602 Common Stock (F3) Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.